Precision BioSciences, Inc. (DTIL) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 9 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for DTIL is $19.00, representing a +162.8% upside from the current price of $7.23. Price targets range from a low of $19.00 to a high of $19.00.
